DK75593D0 - - Google Patents

Info

Publication number
DK75593D0
DK75593D0 DK93755A DK75593A DK75593D0 DK 75593 D0 DK75593 D0 DK 75593D0 DK 93755 A DK93755 A DK 93755A DK 75593 A DK75593 A DK 75593A DK 75593 D0 DK75593 D0 DK 75593D0
Authority
DK
Denmark
Prior art keywords
pct
ammonia lyase
phenylalanine ammonia
sec
variant
Prior art date
Application number
DK93755A
Other languages
Danish (da)
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Priority to DK93755A priority Critical patent/DK75593D0/da
Publication of DK75593D0 publication Critical patent/DK75593D0/da
Priority to US08/556,963 priority patent/US5753487A/en
Priority to DK94919559T priority patent/DK0703788T3/da
Priority to PCT/DK1994/000224 priority patent/WO1995000171A1/en
Priority to ES94919559T priority patent/ES2168297T3/es
Priority to PT94919559T priority patent/PT703788E/pt
Priority to AU70675/94A priority patent/AU7067594A/en
Priority to EP94919559A priority patent/EP0703788B1/en
Priority to DE69429167T priority patent/DE69429167T2/de
Priority to AT94919559T priority patent/ATE209044T1/de
Priority to CA002165281A priority patent/CA2165281A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK93755A 1993-06-25 1993-06-25 DK75593D0 (pt)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DK93755A DK75593D0 (pt) 1993-06-25 1993-06-25
CA002165281A CA2165281A1 (en) 1993-06-25 1994-06-09 A stabilised phenylalanine ammmonia lyase
ES94919559T ES2168297T3 (es) 1993-06-25 1994-06-09 Fenilalanina-amonio-liasa estabilizada.
DK94919559T DK0703788T3 (da) 1993-06-25 1994-06-09 Stabiliseret phenylalaninammoniaklyase
PCT/DK1994/000224 WO1995000171A1 (en) 1993-06-25 1994-06-09 A stabilised phenylalanine ammonia lyase
US08/556,963 US5753487A (en) 1993-06-25 1994-06-09 Stabilised phenylalanine ammonia lyase
PT94919559T PT703788E (pt) 1993-06-25 1994-06-09 Fenilanina-amonio-liasa estabilizada
AU70675/94A AU7067594A (en) 1993-06-25 1994-06-09 A stabilised phenylalanine ammonia lyase
EP94919559A EP0703788B1 (en) 1993-06-25 1994-06-09 A stabilised phenylalanine ammonia lyase
DE69429167T DE69429167T2 (de) 1993-06-25 1994-06-09 Eine stabilisierte phenylalanin-ammonia-lyase
AT94919559T ATE209044T1 (de) 1993-06-25 1994-06-09 Eine stabilisierte phenylalanin-ammonia-lyase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93755A DK75593D0 (pt) 1993-06-25 1993-06-25

Publications (1)

Publication Number Publication Date
DK75593D0 true DK75593D0 (pt) 1993-06-25

Family

ID=8097168

Family Applications (2)

Application Number Title Priority Date Filing Date
DK93755A DK75593D0 (pt) 1993-06-25 1993-06-25
DK94919559T DK0703788T3 (da) 1993-06-25 1994-06-09 Stabiliseret phenylalaninammoniaklyase

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK94919559T DK0703788T3 (da) 1993-06-25 1994-06-09 Stabiliseret phenylalaninammoniaklyase

Country Status (10)

Country Link
US (1) US5753487A (pt)
EP (1) EP0703788B1 (pt)
AT (1) ATE209044T1 (pt)
AU (1) AU7067594A (pt)
CA (1) CA2165281A1 (pt)
DE (1) DE69429167T2 (pt)
DK (2) DK75593D0 (pt)
ES (1) ES2168297T3 (pt)
PT (1) PT703788E (pt)
WO (1) WO1995000171A1 (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3713276B2 (ja) 1995-09-29 2005-11-09 バイオマリン ファーマシューティカル インコーポレイテッド 炎症反応の軽減のためのヘパリナーゼの使用
US5647368A (en) * 1996-02-28 1997-07-15 Xillix Technologies Corp. Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract
US6190883B1 (en) 1998-09-09 2001-02-20 Novo Nordisk A/S Method for the production of heterologous polypeptides in transformed yeast cells
US6368837B1 (en) 1999-08-06 2002-04-09 E. I. Du Pont Nemours And Company Bioproduction of para-hydroxycinnamic acid
US6521748B2 (en) 1999-08-06 2003-02-18 E. I. Du Pont De Nemours And Company Polynucleotide encoding a mutant Rhodotorula glutinis tyrosine ammonia lyase polypeptide
EP1372703A2 (en) * 2001-02-16 2004-01-02 Ibex Technologies Matrix stabilized enzyme crystals and methods of use
US7553653B2 (en) * 2004-09-17 2009-06-30 Biomarin Pharmaceutical Inc. Variants and chemically-modified variants of phenylalanine ammonia-lyase
EP2886658A1 (en) 2005-03-10 2015-06-24 BASF Enzymes LLC Lyase enzymes, nucleic acids encoding them and methods for making and using them
US20070122344A1 (en) 2005-09-02 2007-05-31 University Of Rochester Medical Center Office Of Technology Transfer Intraoperative determination of nerve location
US7534595B2 (en) 2006-06-12 2009-05-19 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US7531341B1 (en) 2006-06-12 2009-05-12 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
US20080161744A1 (en) 2006-09-07 2008-07-03 University Of Rochester Medical Center Pre-And Intra-Operative Localization of Penile Sentinel Nodes
US7560263B2 (en) * 2007-08-17 2009-07-14 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
US8406860B2 (en) 2008-01-25 2013-03-26 Novadaq Technologies Inc. Method for evaluating blush in myocardial tissue
US10219742B2 (en) 2008-04-14 2019-03-05 Novadaq Technologies ULC Locating and analyzing perforator flaps for plastic and reconstructive surgery
WO2009135178A2 (en) 2008-05-02 2009-11-05 Flower Robert W Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics
US9376659B2 (en) * 2008-07-24 2016-06-28 Arch Personal Care Products, L.P. Personal care composition containing yeast/polyphenol ferment extract
WO2010014225A2 (en) * 2008-07-30 2010-02-04 Biomarin Pharmaceutical Inc. Assays for detection of phenylalanine ammonia-lyase and antibodies to phenylalanine ammonia-lyase
US10492671B2 (en) 2009-05-08 2019-12-03 Novadaq Technologies ULC Near infra red fluorescence imaging for visualization of blood vessels during endoscopic harvest
WO2011097335A2 (en) 2010-02-04 2011-08-11 Biomarin Pharmaceutical Inc. Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
CA2803959C (en) 2010-06-30 2021-01-19 Codexis, Inc. Chemically modified carbonic anhydrases useful in carbon capture systems
CA2914778A1 (en) 2012-06-21 2013-12-27 Novadaq Technologies Inc. Quantification and analysis of angiography and perfusion
LT2986722T (lt) 2013-04-18 2019-09-10 Codexis, Inc. Rekombinantiniai fenilalanino amonio liazės polipeptidai
CA2963987A1 (en) 2014-09-29 2016-04-07 Novadaq Technologies Inc. Imaging a target fluorophore in a biological material in the presence of autofluorescence
KR101955134B1 (ko) 2014-10-09 2019-03-06 노바다크 테크놀러지즈 유엘씨 형광-조정 광전용적맥파 측정기를 사용한 조직 내의 절대적인 혈류의 정량화
US11140305B2 (en) 2017-02-10 2021-10-05 Stryker European Operations Limited Open-field handheld fluorescence imaging systems and methods
CN110573175A (zh) * 2017-02-13 2019-12-13 科德克希思公司 工程化苯丙氨酸氨裂合酶多肽

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH564031A5 (pt) * 1968-03-29 1975-07-15 Anvar
IT1096208B (it) * 1978-05-12 1985-08-26 Snam Progetti Composizione adatta alla riduzione del tenore di fenilalanina e metodo impiegante la stessa
FR2523445A1 (fr) * 1982-03-17 1983-09-23 Sanofi Sa Nouveaux conjugues associant, par liaison covalente, une enzyme et un anticorps, et associations medicamenteuses utilisant lesdits conjugues

Also Published As

Publication number Publication date
PT703788E (pt) 2002-05-31
DE69429167T2 (de) 2002-07-04
ATE209044T1 (de) 2001-12-15
EP0703788B1 (en) 2001-11-21
EP0703788A1 (en) 1996-04-03
CA2165281A1 (en) 1995-01-05
US5753487A (en) 1998-05-19
AU7067594A (en) 1995-01-17
DK0703788T3 (da) 2002-05-21
ES2168297T3 (es) 2002-06-16
DE69429167D1 (de) 2002-01-03
WO1995000171A1 (en) 1995-01-05

Similar Documents

Publication Publication Date Title
DK75593D0 (pt)
TW279166B (pt)
FR05C0045I2 (pt)
HK1013283A1 (en) Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MY119820A (en) Guanidine mimics as factor xa inhibitors
UA43348C2 (uk) Водна фармацевтична композиція, що включає фактор росту нерва (варіанти) та ліофілізований фармацевтичний склад
BG104392A (en) Methods for the modulation of serin/treonin protein kinase function with compounds based on 5-azaquinoxaline
DK0707567T3 (da) Fremgangsmåde til syntese af azetidinoner
AU8078394A (en) Amidino derivatives useful as nitric oxide synthase inhibitors
GB9221163D0 (en) Dna compounds
ZA989783B (en) Novel 7-substituted quinazolin-2,4-diones useful as antibacterial agents
DE69228749D1 (de) Neuartige polypeptide und ihre verwendung
HUT72837A (en) Dna encoding a human serotonin receptor (5-ht4b) and uses thereof
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
GR3029700T3 (en) Process for foaming acyloxysilane-containing silicone materials
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
HK1008225A1 (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
GR3024267T3 (en) Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor.
UA39178C2 (uk) Спосіб мінімізації деградації активованого протеїну с (варіанти), фармацевтична композиція та водний розчин активованого протеїну с
HU9601298D0 (en) Endothelin-converting enzyme
WO1994022911A3 (en) A PROCESS AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PREPARATION OF PLATELET GLYCOPROTEIN IIb/IIIa INHIBITORS CONTAINING Nα-METHYLARGININE
MY116275A (en) A pharmaceutical composition for treating dysmenorrhea and premature labor
ZA982808B (en) Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
MX9705218A (es) Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de ginecomastia idiopatica o fisiologica.

Legal Events

Date Code Title Description
A0 Application filed
ATS Application withdrawn